Search Results - "Botta, Cirino"

Refine Results
  1. 1

    AURKA targeting: a NEAT approach to halt myeloma by Solimando, Antonio Giovanni, Botta, Cirino

    Published in Haematologica (Roma) (29-08-2024)
    “…Not available.Not available…”
    Get full text
    Journal Article
  2. 2

    Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response by Sacco, Alessandro, Battaglia, Anna Martina, Botta, Cirino, Aversa, Ilenia, Mancuso, Serafina, Costanzo, Francesco, Biamonte, Flavia

    Published in Cells (Basel, Switzerland) (02-02-2021)
    “…New insights into the field of iron metabolism within the tumor microenvironment have been uncovered in recent years. Iron promotes the production of reactive…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma by Mohammadnezhad, Leila, Shekarkar Azgomi, Mojtaba, La Manna, Marco Pio, Guggino, Giuliana, Botta, Cirino, Dieli, Francesco, Caccamo, Nadia

    “…Primary Sjogren syndrome (pSS) is the second most common autoimmune disorder worldwide, which, in the worst scenario, progresses to Non-Hodgkin Lymphoma (NHL)…”
    Get full text
    Journal Article
  8. 8

    Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility by Biamonte, Flavia, Botta, Cirino, Mazzitelli, Maria, Rotundo, Salvatore, Trecarichi, Enrico Maria, Foti, Daniela, Torti, Carlo, Viglietto, Giuseppe, Torella, Daniele, Costanzo, Francesco

    Published in Journal of translational medicine (17-02-2021)
    “…The Sars-CoV-2 can cause severe pneumonia with multiorgan disease; thus, the identification of clinical and laboratory predictors of the progression towards…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities by Botta, Cirino, Mendicino, Francesco, Martino, Enrica Antonia, Vigna, Ernesto, Ronchetti, Domenica, Correale, Pierpaolo, Morabito, Fortunato, Neri, Antonino, Gentile, Massimo

    Published in Cancers (28-06-2021)
    “…Multiple myeloma (MM) is the second most common hematologic malignancy, characterized by a multi-step evolutionary path, which starts with an early…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment by Botta, Cirino, Cuce, Maria, Caracciolo, Daniele, Fiorillo, Lucia, Tagliaferri, Pierosandro, Tassone, Pierfrancesco

    Published in Current cancer drug targets (01-01-2017)
    “…Multiple myeloma (MM) is an incurable plasma cell neoplasm accounting for about 10% of all hematologic malignancies. Recently, emerging evidence is disclosing…”
    Get more information
    Journal Article
  19. 19

    COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm by Botta, Cirino, Indrieri, Alessia, Garofalo, Eugenio, Biamonte, Flavia, Bruni, Andrea, Pasqua, Pino, Cesario, Francesco, Costanzo, Francesco Saverio, Longhini, Federico, Mendicino, Francesco

    Published in Frontiers in oncology (08-01-2021)
    “…Since SARS-CoV-2 outbreak in December 2019, world health-system has been severely impacted with increased hospitalization, Intensive-Care-Unit (ICU) access and…”
    Get full text
    Journal Article
  20. 20

    Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients by Botta, Cirino, Ciliberto, Domenico, Rossi, Marco, Staropoli, Nicoletta, Cucè, Maria, Galeano, Teresa, Tagliaferri, Pierosandro, Tassone, Pierfrancesco

    Published in Blood advances (28-02-2017)
    “…Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refractory multiple myeloma (RRMM) remains a challenge; the…”
    Get full text
    Journal Article